Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Bupropion for Smoking Cessation
NCT03326128Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Sep 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by University of Southern California. Started Sep 2021; status: terminated.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03326128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326128.